See Your Patients Through Our Eyes

We create software medical devices

We develop software medical devices, powered by a proprietary platform of retaskable intelligent algorithms.

Our non-invasive technology analyzes video, audio and other data to automatically quantify organ-level, system-level and patient-level function

Our advanced biometrics allow medical professionals to make better, more informed clinical decisions

Our products are regulated as medical devices and are delivered as software as a service

FDA agrees:
software should turn data into
information for doctors

“Artificial intelligence (AI) and machine learning (ML) technologies have the potential to transform health care by deriving new and important insights from the vast amount of data generated during the delivery of health care every day.”
AI/ML-Based Software as a Medical Device (SaMD) Action Plan

Our Software Sees So You Can Decide

We develop software medical devices

We deliver comprehensive biometrics

Video, Audio & Data Analysis

Our automated biometric analysis technology is at the core of everything we do at Argus Cognitive. Our software automatically analyzes video, audio and other medical data to produce rich biometrics about your patients.

These rich biometrics give you additional insights into your patients, and frees you up to focus on delivering care instead of recording data.

What You See

Your judgment and expertise are at the core of delivering care to your patients. With your skills and Argus' data, we can see the whole picture.

What We See

Our systems automatically turn qualitative data like video, audio, 3D echo data, and more into rich biometrics that inform you and your patients.


We have active product development programs that address a variety of important medical areas. Our first two products entering the FDA approval process are:

1. ReVISION Award-winning biometric solution to detect a range of debilitating cardiac conditions affecting the right ventricle, such as certain types of heart failure, pulmonary hypertension, and more.

Learn more

2. Neurora behavioral health software for researchers and therapists that delivers rich biometrics such as pauses in speech, repeated words, changes in pitch, and more.

Neurora ASD

Neurora SLP

Please, feel free to reach out for white papers, publication lists, demos, etc. We love partnerships.


Behavioral Health publications

  • Naturalistic, Non-Invasive Method for Capturing Biometric Data during Autism Diagnostic Evaluations

    Khaleel Kamal, András Sarkany, Camille Brune, Emily Dillon, Latha V. Soorya, Zoltán Tősér

    INSAR - International Society for Autism Research / Annual Meeting


    Computational approaches are emerging as promising, objective methods to capture the complex and granular repertoire of behaviors associated with Autism spectrum disorder (ASD). However, developed for exclusive contexts, most tools are limited to specific environments and modalities and require participants to wear devices or restrict their movement by remaining front-facing to the camera. The work presented here focuses on a model of computer vision and machine learning analyses with the capacity to capture and quantify domains of social, language, and early motor behaviors within administration of the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2).

ReVISION publications

  • ReVISION in pediatric cardiology

    Get to the heart of pediatric kidney transplant recipients: Evaluation of left- and right ventricular mechanics by three-dimensional echocardiography

    Zsuzsanna Ladányi, Adrienn Bárczi, Alexandra Fábián, Adrienn Ujvári, Orsolya Cseprekál, Éva Kis, György Sándor Reusz, Attila Kovács, Béla Merkely, and Bálint Károly Lakatos

    Frontiers in Cardiovascular Medicine


    Kidney transplantation (KTX) markedly improves prognosis in pediatric patients with end-stage kidney failure. Still, these patients have an increased risk of developing cardiovascular disease due to multiple risk factors. Three-dimensional (3D) echocardiography allows detailed assessment of the heart and may unveil distinct functional and morphological changes in this patient population that would be undetectable by conventional methods.

More cardiology publications

  • The Impact of COVID-19 on the Preparation for the Tokyo Olympics: A Comprehensive Performance Assessment of Top Swimmers

    Emese Csulak, Árpád Petrov, Tímea Kováts, Márton Tokodi, Bálint Lakatos, Attila Kovács, Levente Staub, Ferenc Imre Suhai, Erzsébet Liliána Szabó, Zsófia Dohy, Hajnalka Vágó, Dávid Becker, Veronika Müller, Nóra Sydó, and Béla Merkely

    International Journal of Environmental Research and Public Health


    Background: The Olympic preparation of athletes has been highly influenced by COVID and post-COVID syndrome. As the complex screening of athletes is essential for safe and successful sports, we aimed to repeat the 2019-year sports cardiology screening of the Olympic Swim Team before the Olympics and to compare the results of COVID and non-COVID athletes...


Argus Cognitive was founded in 2016 by computer scientists, psychologists and a medical device entrepreneur.

  • Zoltan Toser (CEO) and Andras Lorincz (CSO) are computer scientists, specializing in machine learning.

  • Mark Pollack, MD and Latha Soorya, PhD are a practicing psychiatrist and a clinical psychologist.

  • Attila Meretei, MD has been developing medical devices for almost 20 years.

Our product development team is located in Budapest, Hungary.

We maintain a symbiotic relationship with the Neural Information Processing Group at Eotvos Lorand University, Budapest, Hungary, where we can test new technologies before including them in our development pipeline.

In cardiology we closely collaborate with various researchers in the US and Europe.

We are hiring

We are always on the lookout for talented people to join our team. We have openings in the following positions:

Our team is geographically dispersed, present in four continents, so provided you have excellent communication skills, remote work is feasible. Needless to say, good English is a must.

If all this sounds interesting, or you would like more info, don't hesitate to reach out to us at


We have a lot more to say about the company and the team, the unmet need, the market, our technology and products, clinical results and regulatory plans and opportunities in other fields of medicine. If you are interested in a dialogue, collaboration or joining our team, please reach out to us. Thank you!

Zoltan Toser

CEO, Argus Cognitive, Inc.

+1 603 322 1944

Attila Meretei, MD

President, Argus Cognitive, Inc.

+1 603 400 2440

35 South Main Street, Hanover, NH 03755